Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

DMER Releases Pharmacist, Lab Technician CBT Results 2025

Indian pharma sector set for mixed quarter: Report

Ruchika Sharma9 Oct 2024 4:16 PM IST

New Delhi: The Indian pharmaceutical industry is projected to experience a mixed quarter, with slower growth anticipated in the branded formulations,...

Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo Nordisk

Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine

Ruchika Sharma9 Oct 2024 2:33 PM IST

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK)...

Sarosh Shetty to join Piramal Pharma as Interim - CEO of India Consumer Healthcare business, Nitish Bajaj resigns

Ruchika Sharma9 Oct 2024 12:15 PM IST

In a BSE filing, Piramal Pharma has informed that Nitish Bajaj, Chief Executive Officer, India Consumer Healthcare and a Senior Management Personnel...

Alembic Pharma successfully completes USFDA inspection at Panelav Oncology formulation facility

Ruchika Sharma9 Oct 2024 11:20 AM IST

Vadodara: Alembic Pharma has announced that the Company has successfully completed the United States Food and Drug Administration (USFDA)...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

JnJ to discontinue Phase 2 Field Study evaluating investigational antiviral for Dengue prevention

Ruchika Sharma8 Oct 2024 4:50 PM IST

Raritan: Johnson & Johnson has announced it is discontinuing the Phase 2 field study (NCT05201794) evaluating the efficacy of investigational...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Boehringer Ingelheim gets USFDA Breakthrough Therapy designation for survodutide

Ruchika Sharma8 Oct 2024 3:59 PM IST

Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI...

WHO unveils new guideline to improve global access to controlled medicines

Cecolin: WHO adds HPV vaccine for single dose use

Ruchika Sharma8 Oct 2024 12:30 PM IST

WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin has been confirmed for use in a single-dose schedule....

USFDA grants fast track designation to Wockhardt novel antibiotic WCK 6777

Ruchika Sharma8 Oct 2024 10:30 AM IST

Mumbai: Wockhardt has announced that its unique once-a-day, β-lactam enhancer based MDR-active antibiotic, WCK 6777 (Ertapenem/Zidebactam) has...

Dr Reddys Labs secures European Commission approval for biosimilar to treat osteoporosis

Dr Reddy's Labs Switzerland incorporates wholly-owned subsidiary in Denmark

Ruchika Sharma7 Oct 2024 4:55 PM IST

Hyderabad: Dr Reddy's Labs has announced that Dr Reddy's Laboratories SA, Switzerland, ("DRSA") a wholly-owned subsidiary of the Company has...

Sun Pharma unit Taro recalls over 17k units of antifungal medication in US

Medtronic voluntary recalls MiniMed 600 series or 700 series insulin pumps due to potential risks of shortened pump battery life

Ruchika Sharma7 Oct 2024 2:00 PM IST

Galway: Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed 600 series or 700 series...

Natco Pharma gets 7 USFDA observations for Chennai facility

Natco Pharma partner Mylan settles patent litigation with Novo Nordisk over generic Ozempic in US

Ruchika Sharma7 Oct 2024 12:30 PM IST

Hyderabad: NATCO Pharma Limited has announced that its partner Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement of the U.S....

Strides Pharma Science arm New York facility gets 4 USFDA observations

Lupin gets 5 USFDA observations for Pune biotech facility

Ruchika Sharma7 Oct 2024 11:30 AM IST

Mumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with five observations at...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok